24 Nov 2022
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

03 Nov 2022
Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015

28 Oct 2022
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

21 Oct 2022
Laurus Labs outcome of BM October 21, 2022 Corporate Action

21 Oct 2022
Laurus Labs Outcome Ocotber 21, 2022

13 Oct 2022
Laurus Labs Limited Board Meeting On October 21, 2022

13 Oct 2022
Laurus Labs Q2 & 1H FY 23 result con call invite

29 Sep 2022
Laurus Labs Q2 Trading Window Closure 2022-23

17 Sep 2022
Intimation of Schedule of Analyst/ Institutional Investor Meetings pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations 2015

12 Sep 2022
Intimation of Schedule of Analyst/ Institutional Investor Meetings pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations 2015

22 Aug 2022
Stock Ex Intimation Meeting Aug 24 2022FINAL

21 Jul 2022
Laurus labs ltd. Q1 FY 23 results conference call on thursday, july 28, 2022 at 11:00 am IST

19 Jul 2022
Board Meeting Intimation

30 Jun 2022
Grant of Stock Options to the eligible employees

30 Jun 2022
Proceedings of 17111 Annual General Meeting

30 Jun 2022
Disclosure of Voting Results along with the Scrutinizer Report with respect to the 17th Annual General Meeting held on June 30, 2022

29 Jun 2022
Q1 Trading Window Closure

20 Jun 2022
Intimation of Schedule of Analyst/ Institutional Investor Meetings pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations 2015

13 Jun 2022
Intimation of Schedule of Analyst/ Institutional Investor Meetings pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations 2015

09 Jun 2022
Newspaper Advertisement

02 Jun 2022
Newspaper Advertisement

11 May 2022
Disclosure of Related Party Transactions for the half year ended March 31, 2022

11 May 2022
Annual Secretarial Compliance Report for the year ended March 31, 2022

29 Apr 2022
Laurus Labs Q4 FY 22 Earnings Conference Call

29 Apr 2022
Audio Recording of the Q4 & Full Year FY22 Results conference call hosted on April 29, 2022

28 Apr 2022
Corporate Action -02nd Interim Dividend for FY 2021-22

28 Apr 2022
AGM Book Closure FY 2022

28 Apr 2022
AGM Time Change

28 Apr 2022
Initial Disclosure under SEBI circular SEBI/HO/DDHS/CIRJP/2018/144 dated November 26, 2018

25 Apr 2022
Laurus Labs Ltd. Q4 & Full Year Fy22 Results Conference Call

20 Apr 2022
Board Meeting Intimation

07 Apr 2022
Annual Declaration - SAST Reg 31(4)

30 Mar 2022
Laurus Labs Q4 Trading Window Closure 2021-22

22 Mar 2022
Jayasree Form C - 7686 - Buy

14 Mar 2022
Update on schedule of the Analyst/ Institutional Investor Meetings

11 Mar 2022
Intimation of Schedule of Analyst/ Institutional Investor Meetings

28 Feb 2022
Yamini Form C - 2275 Sale

28 Feb 2022
Madhuri Form C - 10K Purchase

21 Feb 2022
Intimation of Schedule of Analyst/ Institutional Investor Meetings

10 Feb 2022
Disclosure under Regulation 30 of LODR Regulations, 2015, as amended

07 Feb 2022
Intimation of Schedule of Analyst/ Institutional Investor Meetings

21 Jan 2022
LAURUS LABS LTD. Q3 & 9M FY22 RESULTS CONFERENCE CALL ON FRIDAY

19 Jan 2022
Laurus Labs Limited Board Meeting On January 27, 2022

30 Dec 2021
Laurus Labs Q3 Trading Window Closure 2021-22

20 Dec 2021
Allotment of Equity Shares on exercise of ESOPs

15 Dec 2021
Chandra kumari Form C 10245 pledg Dec -15,2021

09 Dec 2021
Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 dated November 19,2021

19 Nov 2021
Disclosure of Related Partv Transactions for the half vear ended September 30, 2021

19 Nov 2021
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

17 Nov 2021
SEBI SAST Regulation 29(2) Mrs. Nagarani

17 Nov 2021
SEBI SAST Regulation 29(2) Dr. Satya

17 Nov 2021
NSN Holdings disclosure 29(1) Part-A

15 Nov 2021
NSN Holdings - Disclosure under Reg 10(6) of SAST

08 Nov 2021
NSN Holdings - Disclosure under Reg 10(5) of SAST

28 Oct 2021
Corporate Action - Interim Dividend for FY 2021-22

28 Oct 2021
Outcome of the Board Meeting - October 28, 2021

21 Oct 2021
Laurus Labs Q2 FY 22 result con call invite

20 Oct 2021
Laurus Labs Limited Board Meeting On October 28, 2021

30 Sep 2021
Laurus Labs Q2 Trading Window Closure

17 Sep 2021
Vijaya Kumari Form C 12K Sale

17 Sep 2021
Intimation of Schedule of Analyst/ Institutional Investor Meetings

13 Sep 2021
Intimation of Schedule of Analyst/ Institutional Investor Meetings

07 Sep 2021
Srilakshmi Form C 5000 Sale

02 Sep 2021
AYalamanchi Rama Form C 5500 Sale

13 Aug 2021
Anil Form C 3000 Sale

11 Aug 2021
SS Rao Form C 85777 Sale

11 Aug 2021
Srinivasa Rao S Form C 20000 Sale

10 Aug 2021
Madhuveer Form C 1445 Sale

26 Jul 2021
Laurus Labs Q1 FY 22 results con call invite

19 Jul 2021
Laurus Labs Q1 FY 21-22 Board Meeting July 29, 2021

16 Jul 2021
Disclosure of Voting Results along with the Scrutinizer Report with respect to the 16th Annual General Meeting held on July 15, 2021

15 Jul 2021
Proceedings of 16th Annual General Meeting

07 Jul 2021
Girish Kotapalli Form C 15000 Sale

07 Jul 2021
Narasimha Form C PC and Buy

02 Jul 2021
Venkateswara Rao K Form C 20K PR

01 Jul 2021
Kranthi Form C 1750 Sale

01 Jul 2021
Phanindra Form C 3825 Sale

01 Jul 2021
Narendra Dev Form C 966 Sale

01 Jul 2021
PK Nandi Form C 30K Sale

01 Jul 2021
Sreelakshmi Form C 8000 Sale

01 Jul 2021
Som Parkash Form C 15000 Sale

01 Jul 2021
Satish Kommineni Form C 4000 Sale

01 Jul 2021
Sandhya Rani Form C 2100 Sale

01 Jul 2021
Mohana Form C 5000 Sale

01 Jul 2021
Prathima Chava Form C 1.45 L Sale

30 Jun 2021
Surendra Nath Form C PR and Sale

30 Jun 2021
Jagan Mohana Rao Koya Form C 45K PR and Sale

30 Jun 2021
Closure of Trading Window

29 Jun 2021
Prasad PKV Form C - 65K PC

29 Jun 2021
Giridhar Form C - 65K PC

29 Jun 2021
Murali Mohan P Form C - 35k PC

28 Jun 2021
SS Rao Form C - 2.2L PC

28 Jun 2021
Srinivas Simhadri Form C 13000 Sale

28 Jun 2021
Sita Ramaiah Form C - 35000 Sale

28 Jun 2021
GV Reddy Form C - 2000 Sale

25 Jun 2021
Radha Krishna Form C - 37500 PR

25 Jun 2021
Ratna Kumari Form C - 17500 PR

24 Jun 2021
Ravindra Aduri Form C 15000 Pledge

24 Jun 2021
Naveen Kumar Form C 5000 Sale

24 Jun 2021
Nagi Reddy Form C 2470 Sale

24 Jun 2021
Upgradation in Credit Rating- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

22 Jun 2021
VRN Chowdary Form C 20K Pledge

22 Jun 2021
Venkata Subbarao Form C 900 Sale

22 Jun 2021
Pavan Kumar J Form C 8.5K Pledge

22 Jun 2021
AGM Advertisement

18 Jun 2021
Srinivasa Rao Buddi Form C 2457 Buy

15 Jun 2021
Pavan Elisett -Form C 3465 Sale

15 Jun 2021
Mohana Bikkani Form C 849 Sale

15 Jun 2021
Loka Nagabushan Rao Form C 2375 Sale

14 Jun 2021
Dr. Lakshman Form C 17L Pledge Release

11 Jun 2021
Suneetha Nair Form C 5665 Sale

10 Jun 2021
Venkata Subbarao Form C 3000 Sale

10 Jun 2021
JN Rao Form C 5000 Sale

10 Jun 2021
Ravi Kumar V V Form C 4L Sale

09 Jun 2021
Dr. Lakshman Rao C V Form C 4L Sale

09 Jun 2021
Jagan Mohana Rao K Form C 25000 Sale

09 Jun 2021
GV Reddy Form C 3000 Sale

09 Jun 2021
Dr. Samatha Form C 1700 Sale

09 Jun 2021
Narendra Babu T Form C 2810 Sale

09 Jun 2021
Narendra Dev V Form C 2200 Sale

09 Jun 2021
Babchand Form C 10000 Sale

09 Jun 2021
Babchand Form C 20000 Sale

08 Jun 2021
Sumanth K Form C 2700 Sale

07 Jun 2021
Babchand N Form C 10000 Sale

07 Jun 2021
Pre AGM Notice FY 2020-21

03 Jun 2021
Babchand Form C 10000 Sale

02 Jun 2021
D MVG Rao Form C 2600 Buy

02 jun 2021
Dr. Ravindra Aduri Form C 4376 Sale

01 Jun 2021
VNVPRASAD Form C 17000 Pledge

31 May 2021
Amarchand Form C 3750 Sale

31 May 2021
Madhuveer Form C 2000 Sale

28 May 2021
Tejavathi Form C 3810 Sale

28 May 2021
Mohana Form C 2151 Sale

28 May 2021
Babchand Form C 10000 Sale

26 May 2021
Mani Bushan K Form C 10000 Sale

25 May 2021
Narendra Dev Form C 4500 Sale

24 May 2021
Veeraiah Form C 5000 Sale

21 May 2021
Sridhar Shyam Form C 4300 Sale

21 May 2021
Satish Form C 8139 Buy

18 May 2021
Intimation of Schedule of Analyst/ Institutional Investor Meetings

13 May 2021
Meher Form C 5400 Sale

13 May 2021
Ravi Varma Form C 8160 Pledge/a>

12 May 2021
Veeraiah Form C 3510 Sale

11 May 2021
Pavan E Form C 8418 Sale

11 May 2021
Rajesh Nallani Form C 6440 Pledge

11 May 2021
Murali Apparaju Form C 11000 Sale

05 May 2021
Suresh Form C 9100 - Sale

05 May 2021
GVR Form C 5500 - Sale

04 May 2021
Jagan Form C Sale - 75500

04 May 2021
Navneet Mehta Form C Sale - 10000

04 May 2021
Srinivas Form C 3000 - Sale

29 Apr 2021
Disclosure for a Large Corporate Entity

29 Apr 2021
Intimation of Book Closure pursuant to Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

29 Apr 2021
Corporate Action -3rd Interim Dividend for FY 2020-21

29 Apr 2021
Grant of Stock Options to the eligible employees

29 Apr 2021
Outcome of the Board Meeting - Apri129, 2021

26 Apr 2021
Laurus Labs Ltd. Q4 & Fy21 Results Conference Call On Friday, April 30, 2021 At 11:00 Am IST

22 Apr 2021
Board Meeting Intimation

01 Apr 2021
Form C Mr. Sunder

30 Mar 2021
Laurus labs Q4 Trading Window Closure

23 Mar 2021
Revision in Credit Rating - Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

18 Mar 2021
Form C Chandra Kumari

12 Mar 2021
Form C Mr. Satish

12 Mar 2021
SEBI-SAST-Regulation 31(1)(2)-5750000 - Dr. Satya Pledge Release Bajaj Finance

12 Mar 2021
SEBI-SAST Regulation 31(2)(2)-5750000 - Dr. Satya Pledge Release Tata Capital

12 Mar 2021
SEBI-SAST Regulation 31(1)(2)-6575000 - Dr. Satya Pledge Release AXIS FINANCE

12 Mar 2021
SEBI-SAST Regulation 31(2)(2)-800000 - Dr. Lakshma Pledge Release Adity

12 Mar 2021
Form C Pledge Release Dr. Satya

12 Mar 2021
Form C Pledge Release Dr. Lakshman

11 Mar 2021
Form C Mrs. Nagarani Chava Pledge Release 3750000

12 Mar 2021
SEBI-SAST Regulation 31(1)(2)-3750000 - Mrs. Nagarani Pledge Release AXIS FINANCE

09 Mar 2021
Form C Krishna Kishore JVV

09 Mar 2021
Form C Dr. Ravindra Aduri

08 Mar 2021
Form C Mr. Vijay Krosuri

08 Mar 2021
Form C Mr. DVL Narasimha Rao

04 Mar 2021
Form C Mr. Madhusudan Reddy

04 Mar 2021
Form C 18L S Mrs. Nagarani

04 Mar 2021
Form C 52L S Dr. Satya

17 Feb 2021
Analyst Investor Meetings

16 Feb 2021
Form C Ravikrishna Chebolu

10 Feb 2021
Update on Acquisition of stake in Richcore Lifesciences Private Limited

09 Feb 2021
Form C Mrs. Mahalakshmi M

09 Feb 2021
Form C Dr. MVG Rao

06 Feb 2021
Form C Mrs. Mahalakshmi Malempati

06 Feb 2021
Form C Dr. MVG Rao

04 Feb 2021
Form C Dr. MVG Rao

03 Feb 2021
Form C Mr. PKVPrasad

03 Feb 2021
Form C Mr. Satish

03 Feb 2021
Form C Mr. Babchand N

02 Feb 2021
Intimation of Schedule of Analyst/ Institutional Investor Meetings

01 Feb 2021
Form C Mr. Krishna Kishore JVV

28 Jan 2021
Outcome of the Board Meeting - January 28, 2021

28 Jan 2021
Corporate Action -2nd Interim Dividend for FY 2020-21

20 Jan 2021
Update on Acquisition of stake in Rich core Lifesciences Private Limited

19 Jan 2021
Laurus Labs Limited Board Meeting On 28.01.2021

11 Jan 2021
Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 - incorporation of Step-Down Subsidiary

02 Jan 2021
Form C Dr. Uttam

31 Dec 2020
Form C M. Giridhar

31 Dec 2020
Form C Dr. Samatha

30 Dec 2020
Laurus Labs Q3 Trading Window Closure

29 Dec 2020
Form C Mr. Sridhar Shyam

28 Dec 2020
Mr and Mrs. Satyanarayana Tinnaluri Form C

22 Dec 2020
Form C ESOPS

22 Dec 2020
Allotment of Equity Shares on exercise of ESOPs

18 Dec 2020
Form C Smt. Sarada Kurapati

10 Dec 2020
Form C Dr Satya

09 Dec 2020
SEBI-SAST Regulation 31(1)(2)-2200000-Dr. Satya-Pledge Release - AXIS FINANCE

09 Dec 2020
SEBI-SAST Regulation 31(1)(2)-1100000 Dr. Satya-Pledge Release - AXIS FINANCE

09 Dec 2020
SEBI-SAST Regulation 31(1)(2)-1100000 Dr. Satya-Pledge Creation - AXIS FINANCE

09 Dec 2020
SEBI-SAST Regulation 31(1)(2)-1750000 Dr. Satya-Pledge Release - TATA CAPITAL

09 Dec 2020
Form C Dr Satya

08 Dec 2020
Intimation of Schedule of Analyst/ Institutional Investor Meetings

07 Dec 2020
Form C Mr. PKV Prasad

04 Dec 2020
Form C Naveen Kumar V

02 Dec 2020
Intimation of Schedule of Analyst/ Institutional Investor Meetings

02 Dec 2020
Form C Dr. Vaidyanathan Iyer Narayana Swamy

26 Nov 2020
Conference Call of Laurus Labs Ltd’s Acquisition of Richcore Lifesciences Pvt. Ltd.

25 Nov 2020
Investors/ Analysts Presentation

25 Nov 2020
Laurus Labs Ltd. Acquires Majority Stake In Richcore Lifesciences Conference Call On Thursday

25 Nov 2020
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

23 Nov 2020
Form C Mr. Jagan Mohan

23 Nov 2020
Intimation of Schedule of Analyst/ Institutional Investor Meetings

19 Nov 2020
Intimation of Schedule of Analyst/ Institutional Investor Meetings

19 Nov 2020
Form C S srinivasaRao

19 Nov 2020
Form C Mr. Chandrakanth

13 Nov 2020
Form C Mr. Pavan Kumar Nerella

12 Nov 2020
Form C Mr. Pavan Kumar Nerella

11 Nov 2020
Form C Mr. Murali Krishna

11 Nov 2020
Form C Mr. Chandrakanth

10 Nov 2020
Form C Mr. Krishna Chaitanaya

09 Nov 2020
Form C Mr. Harikrishna K

09 Nov 2020
Form C Mr. Sita Ramaiah

07 Nov 2020
Form C Mr. Chandrakanth

04 Nov 2020
Form C Ms. Soumya

04 Nov 2020
Form C Mr. Chandrakanth

29 Oct 2020
Laurus Labs Corporate Action -Interim Dividend for FY 2020-21

29 Oct 2020
Laurus Labs Approval Letter for reclassification of Shareholding from Promoter Category to Public Category

29 Oct 2020
Laurus Labs Outcome of the Board Meeting 29.10.2020

26 Oct 2020
LAURUS LABS LTD Q2 & H1 FY21 results conference call

19 Oct 2020
Laurus Labs Limited Board Meeting On 29.10.2020

01 Oct 2020
Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Merger of two foreign subsidiaries of the Company

29 Sep 2020
Form C Ms. Rochana Devi R

29 Sep 2020
Closure of Trading Window

28 Sep 2020
Intimation of Schedule of Analyst/ Institutional Investor Meetings

28 Sep 2020
From C Ms. Deepthi

25 Sep 2020
Form C Mr. CNR

23 Sep 2020
From C Dr. Radha Krishna S Spouse PLedge

23 Sep 2020
From C Dr. Radha Krishna S Spouse BUY

22 Sep 2020
Form C Narendra Kumar K

22 Sep 2020
Form C dated 22.09.2020 Dr. Satya Pledge Release

22 Sep 2020
Form C dated 22.09.2020 Mrs. Nagarani Pledge Release

22 Sep 2020
SEBI SAST Regulation 31(1)(2)-225000 Dr. Satya Pledge Release AXIS

22 Sep 2020
SEBI SAST Regulation 31(1)(2)-750000 Mrs. Nagarani Pledge Release AXIS

21 Sep 2020
From C Mr. Tirumal Reddy

21 Sep 2020
Form C Mr. Srinivasa Rao Suryadevara

21 Sep 2020
Form C Dr. Uttam

16 Sep 2020
Form C dated16.09.2020 Dr. Satya Pledge Release

16 Sep 2020
SEBI SAST Regulation 31(1)(2) - 650000 Dr. Satya Pledge Release

16 Sep 2020
From C Dr. Radha Krishna S Spouse

12 Sep 2020
From C Dr. Radha Krishna S

10 Sep 2020
Form C Dr. Lakshman Rao CV

10 Sep 2020
Form C Mr. Satyanarayana Goud K

08 Sep 2020
Form C Mr. Babchand 08.09.2020 Pledge Release

07 Sep 2020
Form C Mudit Singhal

04 Sep 2020
Form C Mr. Babchand

03 Sep 2020
Form C Mrs. S. Rama

02 Sep 2020
Form C Mr. Sita Ramaiah

02 Sep 2020
Form C Mr. Ramakrishna BV

02 Sep 2020
Intimation of Schedule of Analyst/ Institutional Investor Meetings

28 Aug 2020
Form C Ms. Vamsi Rekha

27 Aug 2020
Form C Mr. Rajesh Nallani

18 Aug 2020
Intimation of Schedule of Analyst/ Institutional Investor Meetings

18 Aug 2020
Form C Mr. Ramakrishna Rao K

18 Aug 2020
Form C Ms. Santhi Wo Dr. UMA

17 Aug 2020
From C Dr. MVG Rao

12 Aug 2020
Form C dated 12.08.2020 Dr. Satya Pledge Release and Creation

12 Aug 2020
SEBI SAST Regulation 31(1)(2) - 1500000 Dr. Satya Pledge Creation - TATA

12 Aug 2020
SEBI SAST Regulation 31(1)(2) - 500000 Dr. Satya Pledge Release - BAJAJ

12 Aug 2020
SEBI SAST Regulation 31(1)(2) - 1560000 Dr. Satya Pledge Release - AXIS

10 Aug 2020
Form C Mr. Murali Apparaju

10 Aug 2020
Form C Mr. Suresh Babu M

10 Aug 2020
Form C Mudit Singhal

08 Aug 2020
Form C Mr. P K Nandi

30 Jul 2020
Laurus Labs Outcome of the Board Meeting

30 Jul 2020
Laurus Labs Split Corporate Action

29 Jul 2020
SEBI SAST Regulation 31(1)(2)-2500000 Dr. Satya

29 Jul 2020
Form C dated 29.07.2020 Dr. Satya

27 Jul 2020
Laurus Labs Investor Call

24 Jul 2020
SEBI SAST Dr. SATYA

24 Jul 2020
Form C 24.07.2020

21 Jul 2020
Laurus Labs Board Meeting Intimation Q12020-21

20 Jul 2020
Laurus Labs Application to Stock Exchanges for Reclassification

17 Jul 2020
Form C ESOP

16 Jul 2020
Laurus Labs ESOP Allotment JULY 2020

14 Jul 2020
Form C Mr. Vijay Prakash

11 Jul 2020
Evoting Results 15th AGM

10 Jul 2020
Report on Voting Results of 15th Annual General Meeting

09 Jul 2020
Proceedings of 15th Annual General Meeting

09 Jul 2020
Reclassification of Promoter Category of Dr.Raju

04 Jul 2020
Laurus Labs Update on Acquisition NAME CHANGE

01 Jul 2020
Laurus Labs Addendum to AGM Notice 2020

01 Jul 2020
Laurus Labs Update on Acquisition

01 Jul 2020
Laurus Labs Mr. Narendra Ostawal Resignation

01 Jul 2020
Disclosure Reg 29(2)-Bluewater Investment

30 Jun 2020
SEBI-SAST Regulation 31(1)(2)-2500000-Dr Satya-Pledge Release

30 Jun 2020
SEBI-SAST Regulation 31(1)(2)-2500000-Dr Satya-Pledge Creation

30 Jun 2020
Form C Mr. Chandrakanth

30 Jun 2020
Form C dated 30.06.2020 Mr. CNR

30 Jun 2020
Form C dated 30.06.2020 Dr. Satya-Pledge Release

30 Jun 2020
Form C dated 30.06.2020 Dr. Satya-Pledge Creation

30 Jun 2020
Laurus Labs Q1 Trading Window Closure 2020-21

26 Jun 2020
Form C Dr. Lakshman

26 Jun 2020
Form C Mr. Jagan

25 Jun 2020
Form C Mr. Jagan

25 Jun 2020
Form C Mr. Chandrakanth

18 Jun 2020
SAST Declaration Dr. Satyanarayana C

18 Jun 2020
SAST Declaration Mrs. Nagarani

18 Jun 2020
Form C Mrs. Nagarani

18 Jun 2020
Form C Dr. Satyanarayana C

15 Jun 2020
Laurus Labs AGM Notice FY 2019-20

06 Jun 2020
Laurus Labs News paper Advertisement

28 May 2020
Laurus Labs outcome of Board Meeting Corporate Action

27 May 2020
Disclosure to stock exchanges COVID19

27 May 2020
Laurus Labs RPT Disclosure March 2020

14 May 2020
Form C 14.05.2020

12 May 2020
Disclosure Reg 29(2) SEBI (SAST) Reg.2011 ERML

11 May 2020
Disclosure Reg 29(2) SEBI (SAST) Reg.2011

09 May 2020
Form C 09.05.2020

30 Apr 2020
Outcome of Board Meeting 30.04.2020

27 Apr 2020
Laurus Labs Con Call 30.04.2020

24 Apr 2020
Laurus Labs Board Meeting Intimation

06 Apr 2020
Form C 06.05.2020

06 Apr 2020
Declaration Reg 31 SAST 2011-31.03.2020

06 Apr 2020
Disclosure Reg 30 SAST 2011-31.03.2020

31 Mar 2020
Form C dated 31.03.2020

31 Mar 2020
Form C 31.03.2020

31 Mar 2020
SEBI-SAST Regulation 31(1)(2) 2000000

31 Mar 2020
Form C 31.03.2020

31 Mar 2020
SEBI-SAST Regulation 31(1)(2) 250000

31 Mar 2020
Laurus Labs Q4 Trading Window Closure 2019-20

30 Mar 2020
Form C dated 30.03.2020

26 Mar 2020
Form C dated 26.03.2020

20 Mar 2020
Form C dated 25.03.2020

20 Mar 2020
Laurus Labs Furtherance Letter

20 Mar 2020
SEBI SAST REGULATION 31(1)(2) 2750000

20 Mar 2020
Form C 20.03.2020

20 Mar 2020
Form C 20.03.2020

20 Mar 2020
Form C 20.03.2020

18 Mar 2020
Form C 18.03.2020

17 Mar 2020
Form C 17.03.2020

12 Mar 2020
Laurus Labs out come of Board Meeting 12.03.2020

12 Mar 2020
Laurus Labs outcome of Board Meeting Corporate Action 12.03.2020

04 Mar 2020
Laurus Labs Board Meeting On March-12 04.03.2020

29 Feb 2020
Intimation of Resignation of Independent Director of the Company 29.02.2020

21 Feb 2020
Analyst Investor Meet Intimation 21.02.2020

14 Feb 2020
Form C Regulation 7(2) 14.02.2020

11 Feb 2020
Form C 11.02.2020

06 Feb 2020
Form C 06.02.2020

27 Jan 2020
Laurus Labs Con Call invite Q3 2019-20

23 Jan 2020
Laurus Labs Receives EIR from USFDA

31 Dec 2019
Laurus Labs Board Meeting Intimation Q3 2019-20

31 Dec 2019
Form C 31.12.2019

31 Dec 2019
Form C 31.12.2019

31 Dec 2019
Form C 31.12.2019

31 Dec 2019
Form C 31.12.2019

31 Dec 2019
Form C 31.12.2019 Hyderabad

31 Dec 2019
Form C Pledge 31.12.2019

31 Dec 2019
SEBI SAST Regulation 31(1)(2) Dr. Lakshman

31 Dec 2019
Laurus Labs Trading Window Closure Q3

27 Dec 2019
Form C 27.12.2019

26 Dec 2019
Form C 26-12-2019

26 Dec 2019
Letters for Reclassification

24 Dec 2019
Regulation 7(2) - Dr.Raju 24-12-2019

24 Dec 2019
Form C 24-12-2019

23 Dec 2019
Form C 23-12-2019

23 Dec 2019
SEBI-SAST Regulation 31(1)(2)-90000-Dr.Lakshman

18 Dec 2019
Form C 18-12-2019

16 Dec 2019
Laurus Labs ESOP Grants

07 Dec 2019
Change of Name of Share Transfer Agent

27 Nov 2019
Form C 27-11-2019

25 Nov 2019
Form C 25-11-2019

25 Nov 2019
Analyst Investor Meet Intimation

06 Nov 2019
Laurus Labs RPT Disclosure

29 Oct 2019
Laurus Labs Con Call Invite Q2 2019-20 Results

21 Oct 2019
Laurus Labs Board Meeting Intimation 31 10 2019

01 Oct 2019
Form C 01-10-2019

30 Sep 2019
Laurus Labs trading Window Closure Q2

27 Sep 2019
Form C 27-09-2019

26 Oct 2019
Form C - ESOP 2019

24 Sep 2019
Laurus Labs ESOPs Allotment 2019

24 Sep 2019
SEBI-SAST Regulation 31(1)(2)-100000-Dr Lakshman

24 Sep 2019
Form C 24-09-2019

21 Sep 2019
Form C 21-09-2019

19 Sep 2019
Form C 19-09-2019

08 Sep 2019
Laurus Labs Disclosure Reg 30 Acquisition of Foreign entity in South Africa

06 Sep 2019
Form C 06 Sep 2019

21 Aug 2019
Laurus Labs Intimation of Analyst Investor Call

16 Aug 2019
Form C 16 Aug 2019

09 Aug 2019
Form C 09 Aug 2019

30 July 2019
Laurus Labs Q1 FY2020 Results Conference Call

24 July 2019
Board Meeting Intimation

12 July 2019
Proceedings of 14th Annual General Meeting

12 July 2019
Results of Voting- 14th Annual General Meeting

29 June 2019
Disclosure under Reg 30(1) & 30(2) of SAST Reg 2011.

29 June 2019
Closure of Trading Window.

29 June 2019
Disclosure under Regulation 7(2) of SEBI (PIT) Regulations 2015 .

31 May 2019
Form C 31 May 2019.

31 May 2019
Disclosure on Related Party Transactions.

17 May 2019
Form C.

14 May 2019
Certificate under Regulation 74(5) of the SEBI Regulations 2018.

3 May 2019
Q4 FY19 Conference Call Transcript.

2 May 2019
Intimation of Book Closure pursuant to Regulation 42 of the Securities & Exchange Board of lndia Regulations, 2015.

30 Apr 2019
LAURUS LABS LTD. Q4 & FY19 RESULTS CONFERENCE CALL

30 Apr 2019
Not-applicability of Large Corporate Criteria.

25 Apr 2019
Board Meeting

4 Apr 2019
Closure of Trading Window

2 Apr 2019
Disclosure under Regulation 30 of SEBI Regulations 2011

28 Mar 2019
Disclosure by the promoter(s) to stock exchanges and to the target company for encumbrance of shares

25 Mar 2019
Details of change in holding of Securities of Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2)

21 Mar 2019
Intimation of Schedule of Analyst/ Institutional Investor Meetings pursuant to Regulation 30 of Securities and Exchange Board of India Regulations 2015

19 Mar 2019
Details of change in holding of Securities of promoter, Employee or Director of a listed company and other such persons as mentioned in regulation 6(2)

18 Mar 2019
FIL Capital Disclosure

12 Mar 2019
Details of change in holding of Securities of Promoter, Employee of Director of a listed company and other such person as mentioned in Regulation 6(2)

21 Feb 2019
Intimation of Schedule of Analyst/ Institutional Investor' Meetings pursuant to Regulation 30 of Securities and Exchange Board of India Regulations 2015

18 Feb 2019
Disclosure under Regulation 7(2) read with Regulation 6(2) of SEBI (PIT) Regulations 2015

14 Feb 2019
Disclosure under Regulation 7(2) read with Regulation 6(2) of SEBI (PIT) Regulations 2015

1 Feb 2019
Q3 FY19 Conference Call Transcript

1 Feb 2019
Laurus Labs Q3 & 9M FY19 results concall invite

23 Jan 2019
Board Meeting Intimation

2 Jan 2019
LaurusLabs Disclosure under Reg7(2)of SEBI(PIT) Reg 2015 02 Jan 2019

20 Dec 2018
LaurusLabs Granting of Stock Options to The Eligible Employees

15 Dec 2018
LaurusLabs Disclosure under Reg7(2)of SEBI(PIT) Reg 2015 15 Dec, 2018

1 Dec 2018
Transfer of operations of Share Transfer Agent from Karvy Computershare Private Limited to Karvy Fintech Ptivate Limited

27 Nov 2018
Laurus Labs Disclosure under Reg 7(2) of SEBI(PIT) 2015 27 Nov,2018

15 Nov 2018
LaurusLabs Disclosure under Reg7(2) of SEBI(PIT) Reg 2015 15 Oct,2018

2 Nov 2018
Q2 FY19 Conference Call Transcript

10 Nov 2018
Disclosure under Reg 30(1) & 30(2) of SAST Reg 2011 Dr Satya

10 Nov 2018
Disclosure under Reg 30(1) & 30(2) of SAST Reg 2011 Ms Nagarani

8 Nov 2018
Laurus Labs Disclosure under Reg7(2) of SEBI(PIT) Reg2015 08 Oct, 2018

3 July 2018
Disclsoure under Reg7(2) of SEBI(PIT) Regulations 2015

2 Nov 2018
Disclsoure under Reg7(2) of SEBI(PIT) Regulations 2015

2 Nov 2018
Laurus Labs Q2 & H1 FY 19 Results ConCall Invite

26 Oct 2018
Disclsoure under Reg 7(2) of SEBI (PIT) Regulations 2015 - 26 Oct, 2018

23 Oct 2018
Board Meeting Intimation

11 Oct 2018
Disclsoure under Reg7(2) of SEBI (PIT) Regulations 2015 11-10-2018

06 Oct 2018
Disclsoure under Reg7(2) of SEBI(PIT) Regulations 2015 - 06 Oct 2018

28 Sep 2018
Disclsoure under Reg7(2) of SEBI(PIT)Regulations 2015 28-09-2018

25 Sep 2018
Disclsoure under Reg7 (2) of SEBI (PIT) Regulations 2015 25 Sep 2018

24 Sep 2018
Disclsoure under Reg7(2) of SEBI(PIT) Regulations 2015

20 Sep 2018
Laurus Labs Intimation of Allotment of Sharesunder ESOP Schemes

21 Aug 2018
Disclosure under Reg-7(2) readd with Reg-6(2) of PIT Reg2015 21-Aug-2018

14 Aug 2018
SEBI SAST Reg 31 (1) & (2) - 14.08.2018

13 Aug 2018
Disclosure under Reg-7(2) readd with Reg-6(2) of PIT Reg 2015 13 Aug

9 Aug 2018
Disclosure under Reg 7(2) readd with Reg 6(2) of PIT Reg 2015

4 Aug 2018
Laurus Labs Q1 FY19 Conference Call Transcript

4 Aug 2018
Laurus Labs Q1 FY19 Results Conference Call Intimation

26 July 2018
Board Meeting Intimation 3rd August 2018

Laurus Brochure

6 July 2018
Results of Voting 13th Annual General Meeting

6 July 2018
Proceedings of 13th Annual General Meeting

6 July 2018
Disclosure under Reg 7(2) readd with Reg 6(2) of PIT Reg 2015 - July6 2018

29 June 2018
Disclosure under Regulation Regulations 7(2) read with Regulation 6(2) of SEBI (PIT) 2015

7 June 2018
Disclosure under Regulation Regulations 7(2) read with Regulation 6(2) of SEBI (PIT) 2015 (June 7, 2018)

6 June 2018
SEBI SAST Reg 31 of (1) (2) 6240000

5 June 2018
Disclosure under Regulation 7(2) read with Regulation 6(2) of SEBI (PIT) Regulations 2015

4 June 2018
Intimation of Schedule of Analyst/ Institutional Investor Meetings pursuant to Regulation 30 of Securities and Exchange Board of India Regulations 2015

30 May 2018
SEBI-SAST Reg 31 of (1) (2) - 2790000

31 May 2018
Disclosure under Regulation 7(2) read with Regulation 6(2) of SEBI (PIT) Regulations 2015

30 May 2018
Disclosure under Regulation 7(2) read with Regulation 6(2) of SEBI (PIT) Regulations 2015

29 May 2018
Disclosure under Regulation 7(2) read with Regulation 6(2) of SEBI (PIT) Regulations 2015

11 May 2018
Laurus Labs Q4 FY18 Conference Call Transcript

10 May 2018
Outcome of Board Meeting (May 10,2018)

10 May 2018
Laurus Labs Q4 FY18 Results Conference Call Invitation May 11 2018

10 May 2018
Board Meeting Intimation 10th May 2018

10 April 2018
Reporting under Regulation 29(1)of SEBI-SBI Mutual Funds 10-04-2018

05 April 2018
Disclosure Under Reg(30) of SEBI(SAST)Regulations 2011

31 March 2018
Disclosure under Reg 7(2) of SEBI(PIT) Regulations 2015

8 March 2018
Change in Directorate Appointment of Dr Lakshmana Rao CV

8 March 2018
Resignation of Dr. Srihari Raju Kalidindi

28 February 2018
Analyst - Investor - Meet Intimation 28-02-2018

30 January 2018
Conference Call Transcript Jan 30, 2018

30 January 2018
Laurus Labs Q3 9M FY18 Results Conference Call Invitation (Jan 30, 5 PM)

19 January 2018
Board Meeting Intimation 29th January 2018

26 December 2017
Disclosure under Reg 7(2) of SEBI (PIT) Regulations 2015 Mr.S.Sathyanarayana 26-12-2017

21 December 2017
Disclosure under Reg 7(2) of SEBI (PIT) Regulations 2015 Mr.N.Babchand 19-12-2017

4 December 2017
Analyst - Investor - Meet - Intimation 04-12-2017

30 November 2017
Laurus Labs receives maiden Tentative Approval from USFDA for Tenofovir Disoproxil Fumarate Tablets

24 November 2017
Resignation of Mr. Rajesh Kumar Dugar, Director of Laurus Labs

10 November 2017
Conference Call Transcript 10-11-2017

14 November 2017
Laurus Labs received the EIR for its Units 1 & 3

1 November 2017
Board Meeting Intimation

18 November 2017
Disclosure under Regulation 7(2) Regulation 6(2) of SEBI(PIT) Regulations 2015

11 October 2017
Analyst Investor Meet – Intimation 12-10-2017

21 September 2017
Allotment of Equity Shares on exercise of ESOPs

15 September 2017
Unit 2 receives EIR from USFDA and completes German Regulatory Authority inspection; WHO inspections completed for Unit 1 & 3

4 September 2017
Intimation of Schedule of Analyst/Institutional Investor Meetings Pursuant to Regulation 30 of Securities and Exchange Board of India Regulations 2015

29 August 2017
Intimation of Schedule of Analyst/ Institutional Investor Meetings on August 29, 2017

4 September 2017
Intimation of Schedule of Analyst/Institutional Investor Meetings Pursuant to Regulation 30 of Securities and Exchange Board of India Regulations 2015

11 August 2017
Q1 & FY 2018 Results: Analyst & Investor Call (Aug 11, 2 PM)

1 August 2017
Intimation of Board Meeting

13 July 2017
Proceedings of AGM 12-07-2017

13 July 2017
AGM Voting Results 12-07-2017

31 May 2017
Intimation of Schedule of Analyst / Institutional Investors Meetings pursuant to Retulation 30 of Securities and Exchange Board of India

19 May 2017
Unit 2 USFDA Audit Successful

18 May 2017
Q4 & FY 2017 Results: Investor Presentation

18 May 2017
Outcome of Board Meeting (May 18)

19 May 2017
Q4 & FY 2017 Results: Analyst & Investor Call (May 19)

9 February 2017
Q3 & FY 2017 Results: Investor Presentation

8 May 2017
Announcement

8 May 2017
Intimation of Board Meeting

8 May 2017
Intimation of Demise of Director

27 March 2017
Resignation of Director - Reg

11 March 2017
Disclosures under Regulation 30 of the SEBI

1 March 2017
Disclosure under Reg 7(2) of SEBI (PIT) Regulations 2015 01-03-2017

10 February 2017
Intimation of Conference Call

2 February 2017
Board meeting Intimation for Results & Closure of Trading Window

2 January 2017
Resignation of Director-Conner Town Mulvee

29 December 2016
Change of CIN - Reg

23 December 2016
Disclosure under Reg 7(2) of SEBI (PIT) Regulations 2015_23-12-2016

20 December 2016
Reporting under Regulation 29(1) of SEBI